PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

RHOFADE Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "RHOFADE Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

RHOFADE Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on RHOFADE and covers the following critical aspects of this drug:

  • United States patents
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for RHOFADE
  • US Patents
  • US Regulatory Exclusivity
  • International (ex US) Patents
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Allergan Inc.
  • Sigma-Aldrich
  • Novoseek
  • Mp Biomedicals
  • Akos Consulting & Solutions
  • Finetech Industry Limited
  • Chemmol
  • Abblis Chemicals.Cn
  • Ak Scientific Inc. (Aksci)
  • Chemtik
  • Emd Millipore
  • Nanjing Kaimubo
  • Abachemscene
  • Medchemexpress Mce
  • An Pharmatech
  • Tocris Bioscience
  • Mcule
  • Alsachim
  • Boc Sciences
  • Biosynth
  • Glentham Life Sciences Ltd.
  • Molepedia
  • Ichemical Technology USA Inc
  • Apexbio Technology
  • Abovchem Llc
  • Chemshuttle
  • LGC Standards
  • Clearsynth
  • Ochem
  • Chemieliva Pharmaceutical Co. Ltd
  • Musechem
  • Abcr Gmbh
  • 3B Scientific (Wuhan) Corp
  • Alfa Aesar
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/9lzhnd/rhofade_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005433/en/

Editor Details

Last Updated: 14-Jan-2019